{"id":"W2789468111","doi":"10.1007/s11523-018-0559-0","title":"Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Targeted Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Ipsen; Canadian Centre for Applied Research in Cancer Control","keywords":"Cabozantinib; Medicine; Sunitinib; Internal medicine; Sorafenib; Oncology; Hazard ratio; Renal cell carcinoma; Meta-analysis; Bevacizumab; Temsirolimus; Progression-free survival; Subgroup analysis; Confidence interval; Overall survival; Hepatocellular carcinoma; Chemotherapy; Discovery and development of mTOR inhibitors","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01326933,0.002106196,0.01502668,0.005170755,0.0004756994,0.002403864,0.001761629,0.00169882,0.002621916],"category_scores_gemma":[0.02525306,0.0009984529,0.03249329,0.005039173,0.0005977717,0.001402389,0.001152392,0.001497226,0.0002085181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002875033,"about_ca_system_score_gemma":0.002936114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006892249,"about_ca_topic_score_gemma":0.01571006,"domain_scores_codex":[0.9905292,0.005299923,0.002129673,0.0008954434,0.0009271012,0.0002185884],"domain_scores_gemma":[0.9841573,0.01149651,0.002824371,0.0003757801,0.000920394,0.0002257528],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.004264947,0.00004300761,0.003221062,0.3014999,0.6779147,0.00008183015,0.00006287516,0.0007035677,0.0002194611,0.0001387933,0.0004235854,0.01142627],"study_design_scores_gemma":[0.001320791,0.000297344,0.002632643,0.01621874,0.9777849,0.00005843081,0.00002778804,0.0002916399,0.00008878293,0.0001843285,0.001077439,0.00001715893],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008838572,0.9889542,0.0005613591,0.0002177402,0.0001391125,0.0003877537,0.0005423909,0.00002560206,0.0003333171],"genre_scores_gemma":[0.3506927,0.6421093,0.003054278,0.001035813,0.0002504005,0.001398467,0.001116494,0.00003353655,0.0003090232],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9849733,"threshold_uncertainty_score":0.07017577,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1109176175775262,"score_gpt":0.3834524545767004,"score_spread":0.2725348369991741,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}